icad Inc (ICAD)
1.47
-0.01
(-0.68%)
USD |
NASDAQ |
Apr 26, 14:24
icad Accounts Receivable (Quarterly): 6.392M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.392M |
September 30, 2023 | 4.865M |
June 30, 2023 | 5.747M |
March 31, 2023 | 7.381M |
December 31, 2022 | 5.769M |
September 30, 2022 | 8.472M |
June 30, 2022 | 10.17M |
March 31, 2022 | 10.31M |
December 31, 2021 | 8.891M |
September 30, 2021 | 11.79M |
June 30, 2021 | 11.11M |
March 31, 2021 | 10.65M |
December 31, 2020 | 10.03M |
September 30, 2020 | 8.376M |
June 30, 2020 | 6.658M |
March 31, 2020 | 7.09M |
December 31, 2019 | 9.819M |
September 30, 2019 | 8.002M |
June 30, 2019 | 6.771M |
March 31, 2019 | 7.387M |
December 31, 2018 | 6.403M |
September 30, 2018 | 6.228M |
June 30, 2018 | 6.331M |
March 31, 2018 | 7.283M |
December 31, 2017 | 8.599M |
Date | Value |
---|---|
September 30, 2017 | 7.189M |
June 30, 2017 | 5.477M |
March 31, 2017 | 5.566M |
December 31, 2016 | 5.189M |
September 30, 2016 | 4.727M |
June 30, 2016 | 6.052M |
March 31, 2016 | 5.76M |
December 31, 2015 | 7.488M |
September 30, 2015 | 8.481M |
June 30, 2015 | 7.764M |
March 31, 2015 | 10.33M |
December 31, 2014 | 9.642M |
September 30, 2014 | 11.13M |
June 30, 2014 | 9.631M |
March 31, 2014 | 7.548M |
December 31, 2013 | 7.623M |
September 30, 2013 | 8.419M |
June 30, 2013 | 6.099M |
March 31, 2013 | 5.466M |
December 31, 2012 | 4.98M |
September 30, 2012 | 5.715M |
June 30, 2012 | 3.334M |
March 31, 2012 | 4.44M |
December 31, 2011 | 4.003M |
September 30, 2011 | 5.656M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
4.865M
Minimum
Sep 2023
11.79M
Maximum
Sep 2021
8.331M
Average
8.376M
Median
Sep 2020
Accounts Receivable (Quarterly) Benchmarks
ClearPoint Neuro Inc | 3.211M |
Perspective Therapeutics Inc | 1.165M |
Xtant Medical Holdings Inc | 20.73M |
Asensus Surgical Inc | 3.508M |
Catheter Precision Inc | 0.137M |